|Bid||18.84 x 900|
|Ask||18.95 x 1000|
|Day's range||18.28 - 18.89|
|52-week range||15.00 - 29.44|
|Beta (5Y monthly)||1.00|
|PE ratio (TTM)||N/A|
|Earnings date||01 Nov 2023 - 06 Nov 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||28.71|
AUSTIN, Texas, August 24, 2023--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the following upcoming investor conferences.
While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilon (AGL) delivered earnings and revenue surprises of -300% and 3.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?